scholarly journals Author(iz)ing Death: Medical Aid-in-Dying and the Morality of Suicide

2019 ◽  
Vol 34 (1) ◽  
pp. 53-77 ◽  
Author(s):  
Anita Hannig

In 2017, Oregon marked the twentieth anniversary of enacting the Death with Dignity Act, allowing terminally ill, mentally competent adult patients to end their life by ingesting a lethal medication prescribed by their physician. In U.S. public discourse, medical aid-in-dying is frequently equated with the terminology and morality of suicide, much to the frustration of those who use and administer the law. This article reflects on the stakes of maintaining a distinction between a medically assisted death and the most common cultural category for self-inflicted death—suicide. It uncovers the complicated dialectic between authorship and authorization that characterizes medical assistance in dying and attendant moralities of purposive death, speaking to broader disciplinary concerns in the cultural study of death and medicine. By stressing the primacy of debilitating, life-limiting illness in an aided death and by submitting such a death to the rationale and management of institutionalized medicine, advocates carve out a form of intentional death that occupies a category of its own. The diffusion of agency onto a patient’s fatal illness, medicine, and the state—both discursively and in practice—enhances the moral and social acceptability of an assisted death, which becomes an authorized form of dying that looks very different from the socially deviant act of suicide.

2019 ◽  
Vol 41 (1) ◽  
pp. 53-70 ◽  
Author(s):  
Kimberly A. Lauffer ◽  
Sean D. Baker ◽  
Natalee Seely

In 2016, the District of Columbia City Council passed the Death With Dignity Act. Afterward, Congress attempted to block its implementation by first invoking Congress’s power to overturn the law and then, when unsuccessful in that effort, withhold money from the District. Previous studies examining local news media coverage of aid-in-dying legislation have identified several recurrent frames. D.C. news publications invoked those frames as well as others more specific to the District. Understanding how aid in dying and related legislation is portrayed in newspaper coverage is important as more jurisdictions consider legalization of the practice.


2003 ◽  
Vol 12 (3) ◽  
pp. 310-321 ◽  
Author(s):  
BEN A. RICH

When one considers the protracted and continuing struggle of the citizens of Oregon to include physician-assisted suicide (also known as “physician aid in dying”) among the panoply of measures available to dying patients and the physicians who care for them, the depth and breadth of the issue becomes inescapable. The potential intractability of the dispute is illustrated by the very fact, noted in the preceding parenthetical phrase, that consensus eludes us on even the most basic of semantic points—how we are to most aptly characterize the conduct in question? The case featured in this issue's The Caduceus in Court must be examined as the latest battle in a long war of attrition waged by opponents of physician-assisted suicide against the Oregon Death with Dignity Act (“the Oregon Act”). After briefly reviewing that history, I will then consider the details of Oregon v. Ashcroft and the implications of the litigation not only for the care of dying patients but also for the regulation of medical practice in the United States and, more broadly still, the search for resolution of serious medical disputes in a democratic society.


2020 ◽  
Vol 22 (Supplement_2) ◽  
pp. ii180-ii180
Author(s):  
Jerome Graber ◽  
Kaite Sofie ◽  
Lynne Taylor

Abstract Since 2009, Washington State has had a “Death with Dignity” (DWD) process whereby people with a terminal illness may legally obtain a prescription for medications that will end their life. Patients initiate a voluntary request from two physicians certifying they have a prognosis < 6 months, are aware of other palliative care options, and have capacity without the comorbidity of a psychiatric diagnosis. Since 2015, over 200 people annually have used the DWD process in Washington. Other papers have described the characteristics of people using DWD with a diagnosis of cancer or amyotrophic lateral sclerosis (ALS) but none have specifically looked at patients with brain tumors (BT) who used DWD. We describe 20 people with BT who accessed DWD since 2015 at our center. Median age at the time of death was 51 (range 38-79) and 75% were men. Glioblastoma was the diagnosis in 10 (50%), anaplastic glioma in 8 (40%), grade II astrocytoma in 1, and a presumed high-grade glioma by imaging in 1. Median Karnofsky Performance Status (KPS) was 90 at diagnosis (range 50-100) and 70 at DWD request (range 40-90). Standard radiation (RT) and chemotherapy was used by 17 (85%) prior to DWD request, while 3 patients (15%, ages 70-79, KPS 50-90) requested DWD immediately after diagnosis and did not undergo further treatment. Pain was present in 4 patients (20%), 2 using opioids (10%). Six patients (30%) continued tumor treatments after approval for DWD. Median OS was 22 months (range 2-285) and 24 months excluding patients who declined treatment (range 8-285). Most glioma patients in our cohort requested DWD after undergoing chemoradiation, pain was uncommon and rarely severe, and survival from diagnosis was comparable to standard therapy. As access to medical assistance in dying continues, further research is needed on its utilization for people with brain tumors.


2000 ◽  
Vol 342 (8) ◽  
pp. 557-563 ◽  
Author(s):  
Linda Ganzini ◽  
Heidi D. Nelson ◽  
Terri A. Schmidt ◽  
Dale F. Kraemer ◽  
Molly A. Delorit ◽  
...  

JAMA Oncology ◽  
2018 ◽  
Vol 4 (5) ◽  
pp. 747 ◽  
Author(s):  
Sarah K. Sperling

2012 ◽  
Vol 14 (1) ◽  
pp. 45-52 ◽  
Author(s):  
Anita Jablonski ◽  
Janine Clymin ◽  
Dana Jacobson ◽  
Karen Feldt

Sign in / Sign up

Export Citation Format

Share Document